Evidence map›Paper›PMID 41399531›Full record

ArticleJournal of inflammation research2025

Exploring the Mechanism of CaoHuangGuiXiang Formula in Ameliorating Systemic

Huizhen Yue, Shuhua Liu, Yinglu Bai, Wenjing Zhu, Jinhao Tian, Xiaolong Xu, Qingquan Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Huizhen Yue *Department of Emergency and Critical Care, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, People's Republic of China.ORCID 0009-0001-4618-308X
Shuhua Liu *Department of Emergency and Critical Care, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, People's Republic of China.
Yinglu BaiDepartment of Emergency and Critical Care, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, People's Republic of China.
Wenjing ZhuClinical Medical College, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Jinhao TianClinical Medical College, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Xiaolong XuDepartment of Emergency and Critical Care, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, People's Republic of China.
Qingquan LiuDepartment of Emergency and Critical Care, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: CaoHuangGuiXiang (CHGX) formula is a traditional Chinese medicine (TCM) used for the treatment of Methods: Active ingredients and potential targets of CHGX were identified via the TCMSP, Swiss Target Prediction, and TCMID databases. Systemic Results: A total of 103 active compounds and 279 potential targets of the CHGX formula were identified, yielding 53 common targets between Conclusion: This study elucidates the potential multi-pathway and multi-target mechanisms underlying the therapeutic efficacy of the CHGX formula against

Indexed as

antifungal activityanti-inflammatory effectCaoHuangGuiXiang formulanetwork pharmacologysystemic candidiasis

Identifiers

PMID41399531
PMCPMC12702619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.